Hereditary Malignant Neoplasm — Trials

Hereditary Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

78 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 25
Recruiting: 14
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06895681	UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations	withdrawn	—	0	University of California, San FranciscoOTHER	0	Sep 2, 2026	clinicaltrials
NCT04603365	Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer	withdrawn	Phase 2	0	Jonsson Comprehensive Cancer CenterOTHER	0	May 17, 2023	clinicaltrials